Harris backs slashing medical debt. Trump’s ‘concepts’ worry advocates.

Patient and consumer advocates are looking to Kamala Harris to accelerate federal efforts to help people struggling with medical debt if she prevails in next month’s presidential election.

Boehringer plans NDA filing for pulmonary fibrosis drug following Phase 3 data

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 17, 2024

Biogen edges out competition to win first FDA approval for Actemra biosimilar – Pharmaceutical Technology

Biogen has a biosimilar catalogue that generated $1.95bn in sales in Q2 2023. Image Credits: PictureDesignSwiss/Shutterstock. Biogen has entered the crowded arthritis market in the

October 2, 2023

Abbott looks to ‘highly productive’ device pipeline for future growth

By the numbers Q1 revenue: $9.96 billion 2.2% increase year over year Medical devices revenue: $4.45 billion 14.2% increase year over year Net income: $1.23

April 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.